This archive includes all weekly updates of the figures on the COVID-19 vaccination programme in the Netherlands.

20 December 2022 | 16:00 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September up to and including 18 December 2022, nearly 4 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 58.1%.

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.

There will be no update on the vaccination figures next week (27 December) due to the holidays.

 

Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 50 (2022). 1-2

Age group Birth year Vaccination coverage for repeat vaccination
in autumn round, in relation
to population of the Netherlands
Vaccination coverage for repeat vaccination
in autumn round, in relation
to completed basic series
12 years and older 2010 and before 25.4% 31.6%
18 years and older 2004 and before 27.3% 33.2%
60 years and older 1962 and before 58.1% 62.4%
  1. Source: CIMS+ method
  2. The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..

6 December 2022 | 16:20 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September up to and including 4 December 2022, more than 3.8 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 57.3%.

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.

Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 48 (2022). 1-2

Age group Birth year Vaccination coverage for repeat vaccination
in autumn round, in relation
to population of the Netherlands
Vaccination coverage for repeat vaccination
in autumn round, in relation
to completed basic series
12 years and older 2010 and before 24.9% 31.0%
18 years and older 2004 and before 26.8% 32.5%
60 years and older 1962 and before 57.3% 61.5%
  1. Source: CIMS+ method
  2. The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..

29 November 2022 | 16:00 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September up to and including 27 November 2022, more than 3.8 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 56.6%.

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.

Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 47 (2022). 1-2

Age group Birth year Vaccination coverage for repeat vaccination
in autumn round, in relation
to population of the Netherlands
Vaccination coverage for repeat vaccination
in autumn round, in relation
to completed basic series
12 years and older 2010 and before 24.5% 30.5%
18 years and older 2004 and before 26.3% 32.0%
60 years and older 1962 and before 56.6% 60.8%
  1. Source: CIMS+ method
  2. The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..

22 November 2022 | 16:00 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September up to and including 20 November 2022, more than 2.7 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 55.5%.

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.

Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 46 (2022). 1-2

Age group Birth year Vaccination coverage for repeat vaccination
in autumn round, in relation
to population of the Netherlands
Vaccination coverage for repeat vaccination
in autumn round, in relation
to completed basic series
12 years and older 2010 and before 23.9% 29.7%
18 years and older 2004 and before 25.7% 31.2%
60 years and older 1962 and before 55.5% 59.5%
  1. Source: CIMS+ method
  2. The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.. 

15 November 2022 | 16:00 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September up to and including 15 November 2022, 3.6 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54.2%. 

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. 

Everyone aged 12 years and older now has the option to get a repeat vaccination against COVID-19. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via  planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.

Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 45 (2022). 1-2

Age group Birth year Vaccination coverage for repeat vaccination
in autumn round, in relation
to population of the Netherlands
Vaccination coverage for repeat vaccination
in autumn round, in relation
to completed basic series
12 years and older 2010 and before 23.0% 28.6%
18 years and older 2004 and before 24.8% 30.1%
60 years and older 1962 and before 54.2% 58.1%
  1. Source: CIMS+ method
  2. The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.

8 November 2022 | 16:00 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September up to and including 6 November 2022, 3.4 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 52.1%. 

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. 

Everyone aged 12 years and older now has the option to get a repeat vaccination against COVID-19. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via  planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.

Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 44 (2022). 1-2

Age group Birth year Vaccination coverage for repeat vaccination
in autumn round, in relation
to population of the Netherlands
Vaccination coverage for repeat vaccination
in autumn round, in relation
to completed basic series
12 years and older 2010 and before 21.7% 26.9%
18 years and older 2004 and before 23.4% 28.3%
60 years and older 1962 and before 52.1% 55.8%
  1. Source: CIMS+ method
  2. The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..

1 November 2022 | 16:30 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September up to and including 30 October 2022, more than 3 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 48.7%. 

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. 

Everyone aged 12 years and older now has the option to get a repeat vaccination against COVID-19.  You can make an appointment via planjeprik.nl.

The data flow between GGD-GHOR and RIVM was on hold for a short period. This was due to the preparations for data transfer related to the vaccinations in autumn 2022. Starting tomorrow, RIVM will share open data about COVID-19 vaccination coverage for the repeat vaccination in autumn 2022. 

 

Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 43 (2022). 1-2

Age group Birth year Vaccination coverage for repeat vaccination
in autumn round, in relation
to population of the Netherlands
Vaccination coverage for repeat vaccination
in autumn round, in relation
to completed basic series
12 years and older 2010 and before 19.4% 24,0%
18 years and older 2004 and before 20.9% 25.3%
60 years and older 1962 and before 48.7% 52.1%
  1. Source: CIMS+ method
  2. The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.

 

25 October 2022 | 16:00 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September to 23 October 2022, nearly 2.5 million repeat vaccinations against COVID-19 were administered.  Last week, similar to the week before, most of the repeat vaccinations administered were in the age group of 60 years and older. Vaccination coverage for the repeat vaccination among people over 60 has now reached 42.4%.

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. 

As of this week, everyone aged 12 years and older will have the option to get a repeat vaccination against COVID-19. It will be made available step by step, according to birth year. More information is provided at  Government.nl. 

The data flow between GGD-GHOR and RIVM was on hold for a short period. This was due to the preparations for data transfer related to the vaccinations in autumn 2022. The weekly update on participation in COVID-19 vaccination in the Netherlands was published in PDF format this week. The expectation is that data on COVID-19 vaccination coverage can be shared through our COVID-19 dataset again as of next week.

Table 1.  Number of people vaccinated in the autumn 2022 round (COVID-19 basic series or repeat vaccination), week 38 (2022) to week 42 (2022), by type of vaccinator. 1-2

Vaccinator First dose in basic series Second dose in basic series Repeat vaccination against COVID-19
Municipal Public Health Services (GGD) 2,018 1,162 2,437,443
GPs 3 0 11,195
Other  25 12 43,186
Total 2,046 1,174 2,491,824
  1. Source: CIMS/CoronIT (Municipal Public Health Services – GGD) and CIMS+ (general practitioners and other vaccinators)
  2. The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..

18 October 2022 | 17:00 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September to 16 October 2022, nearly 1.9 million repeat vaccinations against COVID-19 were administered. Most of the repeat vaccinations administered last week were in the age group of 60 years and older.  Vaccination coverage for the repeat vaccination among people over 60 has now reached 33.8%. Vaccination coverage among people over 70 is now 45.8%, and among people over 80 it has reached 45.5%.

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. 

Starting this week, people under 60 will also have the option to get a repeat vaccination against COVID-19. It will be made available step by step, according to birth year. More information is provided at Government.nl. 

Table 1. Number of repeat vaccinations against COVID-19 in the autumn round, week 38 to week 41, 20221-3

Week Cumulative number of repeat vaccinations against COVID-19
38 262,389
39 716,138
40 1,280,663
41 1,893,265
  1. Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
  2. People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.  
  3. People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in these figures. Therefore, these figures are slightly lower than the actual total. 

Table 2. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, week 38 to week 41, 2022 1-3

Age group Birth years Vaccination coverage for
repeat vaccination in autumn round, in relation to population of the Netherlands
Vaccination coverage for
repeat vaccination in autumn round, in relation to completed basic series
60 years and older
70 years and older
1962 and before
1952 and before
33.8 %

45.8 %
37.1 %

49.2 %
  1. Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
  2. People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
  3. People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in the numerator. Therefore, these vaccination coverage figures are slightly lower than the actual totals. 

The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. It is therefore not yet possible to provide a weekly update on participation in COVID-19 vaccination in the Netherlands.  

 


11 October 2022 | 17:00 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September to 9 October 2022, more than 1.2 million repeat vaccinations against COVID-19 were administered. Most of the repeat vaccinations administered last week were in the age group of 70 years and older Vaccination coverage for the repeat vaccination among people over 70 has now reached 36.2%, and among people over 70 it is now 38.1%.

The repeat vaccination is now available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. 

Starting from 4 October 2022, people aged 12 to 59 years who are eligible for the seasonal flu jab receive an invitation from their GP. More information about COVID-19 vaccination, who will be invited and when is provided at Government.nl

Table 1. Number of repeat vaccinations against COVID-19 in the autumn round, week 38 to week 40, 20221-3

Week Cumulative number of repeat vaccinations against COVID-19
38 261,887
39 711,470
40 1,267,913
  1. Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
  2. People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.  
  3. People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in these figures. Therefore, these figures are slightly lower than the actual total. 

Table 2. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, week 38 to week 40, 2022 1-3

Age group Birth years Vaccination coverage for
repeat vaccination in autumn round, in relation to population of the Netherlands
Vaccination coverage for
repeat vaccination in autumn round, in relation to completed basic series
60 years and older
70 years and older
1962 and before
1952 and before
23.4 %

36.2 %
25.7 %

39.0 %
  1. Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
  2. People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
  3. People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in the numerator. Therefore, these vaccination coverage figures are slightly lower than the actual totals. 

The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. It is therefore not yet possible to provide a weekly update on participation in COVID-19 vaccination in the Netherlands.  


4 October 2022 | 16:30 

Vaccination figures for autumn round of COVID-19 repeat vaccination

From 19 September to 2 October 2022, more than 709,600 repeat vaccinations against COVID-19 were administered. Most of the repeat vaccinations administered last week were in the age group of 70 years and older. Vaccination coverage for the repeat vaccination among people over 70 has now reached 22.1%.

The repeat vaccination is now available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. 

Starting today, people aged 12 to 59 years who are eligible for the seasonal flu jab will receive an invitation from their GP. More information about COVID-19 vaccination, who will be invited and when is provided at Government.nl

Table 1. Number of repeat vaccinations against COVID-19 in the autumn round, week 38 to week 39, 20221-3

Week Cumulative number of repeat vaccinations against COVID-19
38 261,535
39 709,622
  1. Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
  2. People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.  
  3. People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in these figures. Therefore, these figures are slightly lower than the actual total. 

Table 2. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, week 38 to week 39, 2022 1-3

Age group Birth years Vaccination coverage for
repeat vaccination in autumn round, in relation to population of the Netherlands
Vaccination coverage for
repeat vaccination in autumn round, in relation to completed basic series
60 years and older
70 years and older
1962 and before
1952 and before
13,3 %

22,1 %
14,5 %

23,8 %
  1. Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
  2. People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
  3. People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in the numerator. Therefore, these vaccination coverage figures are slightly lower than the actual totals. 

The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. It is therefore not yet possible to provide a weekly update on participation in COVID-19 vaccination in the Netherlands.  

27 September 2022 | 16:45 

First vaccination figures for autumn round of COVID-19 repeat vaccination

From this week on, RIVM will start posting updates on vaccination figures for the autumn round of the repeat vaccination against COVID-19. The autumn round started last week, on 19 September 2022. Up to and including Sunday 25 September, more than 261,500 repeat vaccinations had been administered in the autumn round. Most of the repeat vaccinations administered last week were in the age group of 80 years and older. Vaccination coverage for the repeat vaccination among people over 80 has now reached 11.9%.

The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations will be sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. 

As of today, people born in 1949 can make an appointment. More information about COVID-19 vaccination, who will be invited and when is provided at Government.nl

Table 1. Number of repeat vaccinations against COVID-19 in the autumn round, week 38, 20221-3

Week Cumulative number of repeat vaccinations against COVID-19
38 261,535
  1. Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
  2. People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.  
  3. People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in these figures. Therefore, these figures are slightly lower than the actual total. 

Table 2. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, week 38, 2022 1-3

Age group Birth years Vaccination coverage for
repeat vaccination in autumn round, in relation to population of the Netherlands
Vaccination coverage for
repeat vaccination in autumn round, in relation to completed basic series
60 years and older
80 years and older
1962 and before
1942 and before
5,0 %

11,9 %
5,9 %

15,6 %
  1. Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
  2. People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
  3. People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in the numerator. Therefore, these vaccination coverage figures are slightly lower than the actual totals. 

The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. It is therefore not yet possible to provide a weekly update on participation in COVID-19 vaccination in the Netherlands.  

 


13 September 2022 | 15:55

Vaccination figures: 5 to 11 September 2022

The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. Data publication is expected to resume in 1 to 2 weeks.


6 September 2022 | 16:00

Vaccination figures: 29 August to 4 September 2022

Up to and including Sunday 4 September, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54,4%. 

Numbers and vaccination coverage for COVID-19 booster vaccination

Almost 9.3 million booster jabs have been administered. 64% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.8% of all people over 18 years old have completed the basic series. 80.8% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 4 September 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 35 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 104,501 103,103 207,604
GGD 85-89 1933-1937 29 January 2021 236,697 233,779 470,476
GGD 80-84 1938-1942 5 February 2021 433,806 428,39 862,196
GGD 75-79 1943-1947 6 March 2021 714,828 702,551 1,417,379
GGD 70-74 1948-1952 6 April 2021 822,326 800,314 1,622,640
GGD 65-69 1953-1957 19 April 2021 513,545 500,42 1,013,965
GGD 60-64 1958-1962   495,266 486,792 982,058
GGD 55-59 1962-1967 27 April 2021 1,035,215 870,385 1,905,600
GGD 50-54 1968-1972 20 May 2021 1,018,333 842,577 1,860,910
GGD 45-49 1973-1977 26 May 2021 813,69 694,815 1,508,505
GGD 40-44 1978-1982 29 May 2021 776,568 700,47 1,477,038
GGD 35-39 1983-1987 1 June 2021 760,806 671,306 1,432,112
GGD 30-34 1988-1992 7 June 2021 769,804 663,738 1,433,542
GGD 25-29 1993-1997 11 June 2021 736,074 594,234 1,330,308
GGD 18-24 1998-2004 15 June 2021 1,091,395 823,426 1,914,821
GGD 12-17 2005-2010 22 June 2021 681,672 596,539 1,278,211
GGD 5-11 2011-2017 18 January 2022 61,877 27,891 89,768
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,143,741 1,059,203 2,202,944
Other vaccinators (estimated)     6 January 2021 640,81 471,099 1,111,909
Total       12,850,959 11,271,036 24,121,995

 

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 35, 2022, by type of vaccinator.

  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 35, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.7% 80.8%
18 years and older 2004 and before 83.5% 82.8%

 

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 35, 20221-4

  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

30 August 2022 | 16:00

Vaccination figures: 22 to 28 August 2022

Up to and including Sunday 28 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54,2%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Numbers and vaccination coverage for COVID-19 booster vaccination

Almost 9.3 million booster jabs have been administered. 64% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.8% of all people over 18 years old have completed the basic series. 80.8% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 28 August 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 34 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 104,768 103,365 208,133
GGD 85-89 1933-1937 29 January 2021 237,002 234,08 471,082
GGD 80-84 1938-1942 5 February 2021 434,1 428,682 862,782
GGD 75-79 1943-1947 6 March 2021 715,173 702,883 1,418,056
GGD 70-74 1948-1952 6 April 2021 822,535 800,508 1,623,043
GGD 65-69 1953-1957 19 April 2021 513,669 500,535 1,014,204
GGD 60-64 1958-1962   495,34 486,864 982,204
GGD 55-59 1962-1967 27 April 2021 1,035,328 870,467 1,905,795
GGD 50-54 1968-1972 20 May 2021 1,018,451 842,68 1,861,131
GGD 45-49 1973-1977 26 May 2021 813,806 694,928 1,508,734
GGD 40-44 1978-1982 29 May 2021 776,692 700,58 1,477,272
GGD 35-39 1983-1987 1 June 2021 760,957 671,446 1,432,403
GGD 30-34 1988-1992 7 June 2021 770,011 663,884 1,433,895
GGD 25-29 1993-1997 11 June 2021 736,427 594,478 1,330,905
GGD 18-24 1998-2004 15 June 2021 1,091,661 823,626 1,915,287
GGD 12-17 2005-2010 22 June 2021 681,644 596,502 1,278,146
GGD 5-11 2011-2017 18 January 2022 61,788 27,811 89,599
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,144,137 1,059,541 2,203,678
Other vaccinators (estimated)     6 January 2021 641,368 471,628 1,112,996
Total       12,854,862 11,274,492 24,129,354

 

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 34, 2022, by type of vaccinator.

  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 34, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.7% 80.8%
18 years and older 2004 and before 83.6% 82.8%

 

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 34, 20221-4

  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

23 August 2022 | 16:00

Vaccination figures: 15 to 21 August 2022

Up to and including Sunday 21 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Numbers and vaccination coverage for COVID-19 booster vaccination

Almost 9.3 million booster jabs have been administered. 63.9% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.8% of all people over 18 years old have completed the basic series. 80.8% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 21 August 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 33 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 105,082 103,672 208,754
GGD 85-89 1933-1937 29 January 2021 237,326 234,406 471,732
GGD 80-84 1938-1942 5 February 2021 434,416 428,995 863,411
GGD 75-79 1943-1947 6 March 2021 715,519 703,217 1,418,736
GGD 70-74 1948-1952 6 April 2021 822,724 800,695 1,623,419
GGD 65-69 1953-1957 19 April 2021 513,762 500,625 1,014,387
GGD 60-64 1958-1962   495,384 486,91 982,294
GGD 55-59 1962-1967 27 April 2021 1,035,424 870,535 1,905,959
GGD 50-54 1968-1972 20 May 2021 1,018,500 842,734 1,861,234
GGD 45-49 1973-1977 26 May 2021 813,861 694,964 1,508,825
GGD 40-44 1978-1982 29 May 2021 776,765 700,644 1,477,409
GGD 35-39 1983-1987 1 June 2021 761,014 671,491 1,432,505
GGD 30-34 1988-1992 7 June 2021 770,1 663,955 1,434,055
GGD 25-29 1993-1997 11 June 2021 736,534 594,558 1,331,092
GGD 18-24 1998-2004 15 June 2021 1,091,803 823,716 1,915,519
GGD 12-17 2005-2010 22 June 2021 681,578 596,428 1,278,006
GGD 5-11 2011-2017 18 January 2022 61,71 27,782 89,492
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,144,526 1,059,904 2,204,430
Other vaccinators (estimated)     6 January 2021 641,923 472,165 1,114,088
Total       12,857,956 11,277,400 24,135,356

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 33, 2022, by type of vaccinator.

  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 33, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.7% 80.8%
18 years and older 2004 and before 83.6% 82.8%

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 33, 20221-4

  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

16 August 2022 | 16:30

Vaccination figures: 8 to 14 August 2022

Up to and including Sunday 14 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 53.7%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Numbers and vaccination coverage for COVID-19 booster vaccination

Almost 9.3 million booster jabs have been administered. 63.9% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.8% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 14 August 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 32 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 105,385 103,973 209,358
GGD 85-89 1933-1937 29 January 2021 237,605 234,681 472,286
GGD 80-84 1938-1942 5 February 2021 434,715 429,288 864,003
GGD 75-79 1943-1947 6 March 2021 715,798 703,488 1,419,286
GGD 70-74 1948-1952 6 April 2021 822,933 800,892 1,623,825
GGD 65-69 1953-1957 19 April 2021 513,853 500,713 1,014,566
GGD 60-64 1958-1962   495,43 486,949 982,379
GGD 55-59 1962-1967 27 April 2021 1,035,499 870,589 1,906,088
GGD 50-54 1968-1972 20 May 2021 1,018,556 842,778 1,861,334
GGD 45-49 1973-1977 26 May 2021 813,927 695,014 1,508,941
GGD 40-44 1978-1982 29 May 2021 776,834 700,695 1,477,529
GGD 35-39 1983-1987 1 June 2021 761,052 671,52 1,432,572
GGD 30-34 1988-1992 7 June 2021 770,168 663,988 1,434,156
GGD 25-29 1993-1997 11 June 2021 736,64 594,615 1,331,255
GGD 18-24 1998-2004 15 June 2021 1,091,956 823,807 1,915,763
GGD 12-17 2005-2010 22 June 2021 681,498 596,359 1,277,857
GGD 5-11 2011-2017 18 January 2022 61,597 27,715 89,312
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,144,881 1,060,238 2,205,119
Other vaccinators (estimated)     6 January 2021 642,507 472,721 1,115,228
Total       12,860,839 11,280,027 24,140,866
  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 32, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.7% 80.9%
18 years and older 2004 and before 83.6% 82.8%
  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

9 August 2022 | 16:00

Vaccination figures: 1 to 7 August 2022

Up to and including Sunday 7 August, almost 2.6 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 53.2%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Numbers and vaccination coverage for COVID-19 booster vaccination

Almost 9.3 million booster jabs have been administered. 63.9% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 7 August 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 31 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 105,617 104,204 209,821
GGD 85-89 1933-1937 29 January 2021 237,938 235,009 472,947
GGD 80-84 1938-1942 5 February 2021 435,03 429,594 864,624
GGD 75-79 1943-1947 6 March 2021 716,096 703,778 1,419,874
GGD 70-74 1948-1952 6 April 2021 823,099 801,056 1,624,155
GGD 65-69 1953-1957 19 April 2021 513,949 500,807 1,014,756
GGD 60-64 1958-1962   495,462 486,974 982,436
GGD 55-59 1962-1967 27 April 2021 1,035,571 870,64 1,906,211
GGD 50-54 1968-1972 20 May 2021 1,018,629 842,83 1,861,459
GGD 45-49 1973-1977 26 May 2021 814,011 695,071 1,509,082
GGD 40-44 1978-1982 29 May 2021 776,931 700,792 1,477,723
GGD 35-39 1983-1987 1 June 2021 761,121 671,597 1,432,718
GGD 30-34 1988-1992 7 June 2021 770,25 664,048 1,434,298
GGD 25-29 1993-1997 11 June 2021 736,759 594,68 1,331,439
GGD 18-24 1998-2004 15 June 2021 1,092,069 823,86 1,915,929
GGD 12-17 2005-2010 22 June 2021 681,441 596,3 1,277,741
GGD 5-11 2011-2017 18 January 2022 61,544 27,677 89,221
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,145,169 1,060,490 2,205,659
Other vaccinators (estimated)     6 January 2021 643,032 473,215 1,116,247
Total       12,863,723 11,282,626 24,146,349

 

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 31, 2022, by type of vaccinator.

  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 31, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.7% 80.9%
18 years and older 2004 and before 83.6% 82.9%

2 August 2022 | 16:00

Vaccination figures: 25 to 31 July 2022

Up to and including Sunday 31 July, almost 2.6 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 52.2%.  Almost 70.000 repeat vaccinations have been administered in the past week. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Numbers and vaccination coverage for COVID-19 booster vaccination

Almost 9.3 million booster jabs have been administered. 63.9% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab. 

It is still possible to get a COVID-19 vaccination as a booster jab or repeat vaccination. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 31 July 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 30 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 105,924 104,501 210,425
GGD 85-89 1933-1937 29 January 2021 238,277 235,345 473,622
GGD 80-84 1938-1942 5 February 2021 435,343 429,903 865,246
GGD 75-79 1943-1947 6 March 2021 716,386 704,058 1,420,444
GGD 70-74 1948-1952 6 April 2021 823,307 801,264 1,624,571
GGD 65-69 1953-1957 19 April 2021 514,048 500,902 1,014,950
GGD 60-64 1958-1962   495,511 487,019 982,53
GGD 55-59 1962-1967 27 April 2021 1,035,701 870,734 1,906,435
GGD 50-54 1968-1972 20 May 2021 1,018,720 842,896 1,861,616
GGD 45-49 1973-1977 26 May 2021 814,106 695,141 1,509,247
GGD 40-44 1978-1982 29 May 2021 777,054 700,91 1,477,964
GGD 35-39 1983-1987 1 June 2021 761,302 671,727 1,433,029
GGD 30-34 1988-1992 7 June 2021 770,383 664,136 1,434,519
GGD 25-29 1993-1997 11 June 2021 736,934 594,75 1,331,684
GGD 18-24 1998-2004 15 June 2021 1,092,287 823,963 1,916,250
GGD 12-17 2005-2010 22 June 2021 681,371 596,179 1,277,550
GGD 5-11 2011-2017 18 January 2022 61,451 27,628 89,079
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,145,539 1,060,815 2,206,354
Other vaccinators (estimated)     6 January 2021 643,586 473,743 1,117,329
Total       12,867,235 11,285,618 24,152,853
  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 30, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.8% 80.9%
18 years and older 2004 and before 83.6% 82.9%
  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

 26 July 2022 | 16:15

Vaccination figures: 18 to 24 July 2022

Up to and including Sunday 24 July, more than 2.5 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 50.9%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.2 million booster jabs have been administered. 63.8% of all people over 18 have received a booster jab. 59.2% of all people over 12 have received a booster jab. 

It is still possible to get a COVID-19 vaccination as a booster jab or repeat vaccination. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 24 July 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 29 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 106,214 104,791 211,0015
GGD 85-89 1933-1937 29 January 2021 238,632 235,692 474,324
GGD 80-84 1938-1942 5 February 2021 435,678 430,230 865,908
GGD 75-79 1943-1947 6 March 2021 716,680 704,337 1,624,988
GGD 70-74 1948-1952 6 April 2021 823.518 801.470 1,625,404
GGD 65-69 1953-1957 19 April 2021 514.152 501.003 1.015.155
GGD 60-64 1958-1962   495.553 487.055 982.6908
GGD 55-59 1963-1967 27 April 2021 1,035,784 870,803 1,906,587
GGD 50-54 1967-1972 20 May 2021 1,018,811 842,948 1,861,759
GGD 44-49 1973-1977 26 May 2021 814,190 695,209 1,509,399
GGD 40-44 1978-1982 29 May 2021 777,150 700,987 1,478,137
GGD 35-39 1983-1987 1 June 2021 761,424 671,818 1,433,242
GGD 30-34 1989-1992 7 June 2021 770,493 664,235 1,434,728
GGD 25-29 1993-1997 11 June 2021 737,047 594,806 1,331,853
GGD 18-24 1998-2004 15 June 2021 1,092,403 823,929 1,916,332
GGD 12-17 2005-2010 22 June 2021 681,237 595,820 1,277,057
GGD 5-11 2011-2017 18 January 2022 61,306 27,534 88,840
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,145,923 1,061,144 2,207,067
Other vaccinators (estimated)     06 January 2021 644,154 474,252 1,118,406
Total       12,870.354 11,288.067 24,158,421

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 26, 2022, by type of vaccinator.

  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 29, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.8% 80.9%
18 years and older 2004 and before 83.7% 82.9%

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 26, 20221-4

  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

19 July 2022 | 16:00

Vaccination figures: 11 to 17 July 2022

Up to and including Sunday 17 July, more than 2.4 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 49.3%. Over 100,000 repeat vaccinations were administered last week. This is the highest number of repeat vaccinations in one week within the past three months. The strongest increase was seen among people in their 70s and 80s. Those age groups received twice as many repeat vaccinations last week compared to the week before that. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.2 million booster jabs have been administered. 63.6% of all people over 18 have received a booster jab. 59.1% of all people over 12 have received a booster jab.

It is still possible to get a COVID-19 vaccination as a booster jab or repeat vaccination. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 17 July 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 28 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 106,516 105,085 211,601
GGD 85-89 1933-1937 29 January 2021 238,946 235,996 474,942
GGD 80-84 1938-1942 5 February 2021 436,006 430,551 866,557
GGD 75-79 1943-1947 6 March 2021 716,983 704,638 1,421,621
GGD 70-74 1948-1952 6 April 2021 823.726 801.678 1,625,404
GGD 65-69 1953-1957 19 April 2021 514.231 501.084 1.015.315
GGD 60-64 1958-1962   495.585 487.094 982.679
GGD 55-59 1963-1967 27 April 2021 1,035,849 870,857 1,906,706
GGD 50-54 1967-1972 20 May 2021 1,018,874 842,984 1,861,858
GGD 44-49 1973-1977 26 May 2021 814,247 695,232 1,509,479
GGD 40-44 1978-1982 29 May 2021 777,236 701,053 1,478,289
GGD 35-39 1983-1987 1 June 2021 761,504 671,874 1,433,378
GGD 30-34 1989-1992 7 June 2021 770,551 664,274 1,434,825
GGD 25-29 1993-1997 11 June 2021 737,105 594,834 1,331,939
GGD 18-24 1998-2004 15 June 2021 1,092,450 823,876 1,916,326
GGD 12-17 2005-2010 22 June 2021 680,973 595,289 1,276.262
GGD 5-11 2011-2017 18 January 2022 61,093 27,397 88,490
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,146,333 1,061,539 2,207,872
Other vaccinators (estimated)     06 January 2021 644,723 474,749 1,119,472
Total       12,872.936 11,290.088 24,163,024
  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 28, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.8% 80.9%
18 years and older 2004 and before 83.7% 82.9%
  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

12 July 2022 | 16:00

Vaccination figures: 4 to 10 July 2022

Up to and including Sunday 10 July, more than 2.3 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 47.3%. 

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.2 million booster jabs have been administered. 63.6% of all people over 18 have received a booster jab. 59.1% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.

It is still possible to get a COVID-19 vaccination as part of the basic series, as a booster jab or as a repeat vaccination.

Incorporating the latest population data

Once every quarter, the latest population data is incorporated into the weekly updates. The current population data for July 2022 were used in this weekly update. The age groups have also been adjusted, and the formula used to calculate age has been updated to 2022 minus year of birth. Vaccination coverage is slightly lower after these adjustments. Vaccination coverage for the basic series is down by 1% following the adjustments.

Vaccination figures: 6 January 2021 – 10 July 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 26 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 90+ 1932 and earlier 26 January 2021 106,784 105,346 212,130
GGD 85-89 1933-1937 29 January 2021 239,257 236,307 475,564
GGD 80-84 1938-1942 5 February 2021 436,315 430,851 867,166
GGD 75-79 1943-1947 6 March 2021 717,247 704,904 1,422,151
GGD 70-74 1948-1952 6 April 2021 823,930 801,867 1,625,797
GGD 65-69 1953-1957 19 April 2021 514,329 501,177 1,015,506
GGD 60-64 1958-1962   495,627 487,130 982,757
GGD 55-59 1963-1967 27 April 2021 1,035,911 870,899 1,906,810
GGD 50-54 1967-1972 20 May 2021 1,018,939 843,012 1,861,951
GGD 44-49 1973-1977 26 May 2021 814,315 695,285 1,509,600
GGD 40-44 1978-1982 29 May 2021 777,314 701,100 1,478,414
GGD 35-39 1983-1987 1 June 2021 761,569 671,915 1,433,484
GGD 30-34 1989-1992 7 June 2021 770,563 664,253 1,434,816
GGD 25-29 1993-1997 11 June 2021 737,136 594,826 1,331,962
GGD 18-24 1998-2004 15 June 2021 1,092,519 823,729 1,916,248
GGD 12-17 2005-2010 22 June 2021 680,524 594,451 1,274,975
GGD 5-11 2011-2017 18 January 2022 60,750 27,211 87,961
GGD Unknown Unknown   5 4 9
GPs (estimated)     15 February 2021 1,146,699 1,061,864 2,208,563
Other vaccinators (estimated)     06 January 2021 645,267 475,276 1,120,543
Total       12,875,000 11,291,407 24,155,407
  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 27, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2010 and before 81.8% 80.9%
18 years and older 2004 and before 83.7% 82.9%
  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

5 July 2022 | 16:00

Vaccination figures: 27 June – 3 July 2022

Up to and including Sunday 3 July, more than 2.2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 47.1%. For the past 3 weeks, the weekly number of repeat vaccinations has been increasing. More than twice as many repeat vaccinations were administered last week compared to the week of 6 June. The strongest increase was seen among people aged 60-69 years. 

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.2 million booster jabs have been administered. 64.3% of all people over 18 have received a booster jab. 59.7% of all people over 12 have received a booster jab. The weekly number of booster jabs has been increasing for 3 weeks now. Nearly twice as many booster jabs were administered last week compared to the week of 6 June. The strongest increase was seen among people aged 12-25 years. 

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 83.1% of all people over 18 years old have completed the basic series. 81.9% of all people over 12 years old have completed the basic series.

It is still possible to get a COVID-19 vaccination as part of the basic series, as a booster jab or as a repeat vaccination.   

Vaccination figures: 6 January 2021 – 3 July 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 26 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 91+ 1930 and earlier 26 January 2021 56,772 55,976 112,748
GGD 86-90 1931-1935 29 January 2021 172,377 170,247 342,624
GGD 81-85 1936-1940 5 February 2021 359,918 355,466 715,384
GGD 76-80 1941-1945 6 March 2021 558,881 550,797 1,109,678
GGD 71-75 1946-1950 6 April 2021 848,654 829,206 1,677,860
GGD 66-70 1951-1955 19 April 2021 795,224 771,059 1,566,283
GGD 61-65 1956-1960   145,349 159,632 304,981
GGD 56-60 1961-1965 27 April 2021 1,024,958 965,69 1,990,648
GGD 51-55 1966-1970 20 May 2021 1,037,850 767,082 1,804,932
GGD 46-50 1971-1975 26 May 2021 891,264 815,721 1,706,985
GGD 41-45 1976-1980 29 May 2021 783,168 662,58 1,445,748
GGD 36-40 1981-1985 1 June 2021 759,721 676,317 1,436,038
GGD 31-35 1986-1990 7 June 2021 771,026 672,84 1,443,866
GGD 26-30 1991-1995 11 June 2021 754,806 629,928 1,384,734
GGD 18-25 1996-2003 15 June 2021 1,233,179 919,153 2,152,332
GGD 12-17 2004-2009 22 June 2021 800,163 711,678 1,511,841
GGD 5-11 2010-2016 18 January 2022 87,869 39,386 127,255
GGD Unknown Unknown   1,418 759 2,177
GPs (estimated)     15 February 2021 1,147,110 1,062,154 2,209,264
Other vaccinators (estimated)     6 January 2021 645,718 475,77 1,121,488
Total       12,875,425 11,291,441 24,166,866
  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 26, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 82,7% 81,9%
18 years and older 2003 and before 83,9% 83,1%
  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

28 June 2022 | 16:30

Vaccination figures: 20 June – 26 June 2022

Up to and including Sunday 26 June 2022, more than 2.2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 45.7%. For the past two weeks, the weekly number of repeat vaccinations has been increasing. 59% more repeat vaccinations were administered last week compared to the week of 6 June. The strongest increase was seen in the age group of people aged 60 to 70 years. 

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered. 64.2% of all people over 18 have received a booster jab. 59.6% of all people over 12 have received a booster jab. Since last week, the weekly number of booster jabs has also been increasing. 31% more booster jabs were administered last week compared to the week of 13 June. The strongest increase was seen in the age group of young people aged 12 to 19 years. 

Everyone who has been invited to get a booster jab or repeat vaccination against COVID-19, but has not yet done so, can still get the jab.   

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 83.1% of all people over 18 years old have completed the basic series. 81.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 26 June 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 25 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 91+ 1930 and earlier 26 January 2021 56,953 56,152 113,105
GGD 86-90 1931-1935 29 January 2021 172,677 170,541 343,218
GGD 81-85 1936-1940 5 February 2021 360,259 355,803 716,062
GGD 76-80 1941-1945 6 March 2021 559,197 551,109 1,110,306
GGD 71-75 1946-1950 6 April 2021 848,931 829,482 1,678,413
GGD 66-70 1951-1955 19 April 2021 795,397 771,234 1,566,631
GGD 61-65 1956-1960   145,365 159,643 305,008
GGD 56-60 1961-1965 27 April 2021 1,025,076 965,799 1,990,875
GGD 51-55 1966-1970 20 May 2021 1,037,926 767,124 1,805,050
GGD 46-50 1971-1975 26 May 2021 891,326 815,756 1,707,082
GGD 41-45 1976-1980 29 May 2021 783,236 662,61 1,445,846
GGD 36-40 1981-1985 1 June 2021 759,797 676,349 1,436,146
GGD 31-35 1986-1990 7 June 2021 771,165 672,933 1,444,098
GGD 26-30 1991-1995 11 June 2021 754,897 629,943 1,384,840
GGD 18-25 1996-2003 15 June 2021 1,233,303 919,034 2,152,337
GGD 12-17 2004-2009 22 June 2021 799,969 711,144 1,511,113
GGD 5-11 2010-2016 18 January 2022 86,841 38,592 125,433
GGD Unknown Unknown   1,378 739 2,117
GPs (estimated)     15 February 2021 1,147,479 1,062,490 2,209,969
Other vaccinators (estimated)     6 January 2021 646,282 476,295 1,122,577
Total       12,877,454 11,292,772 24,170,226

 

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 25, 2022, by type of vaccinator.

  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 25, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 82,8% 81,9%
18 years and older 2003 and before 83,9% 83,1%

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 25, 20221-4

  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 

21 June 2022 | 16:00

Vaccination figures: 13 June – 19 June 2022

Up to and including Sunday 19 June 2022, more than 2.1 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 44.2%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered. 64.1% of all people over 18 have received a booster jab. 59.5% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 83.2% of all people over 18 years old have completed the basic series. 81.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 19 June 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 24 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 91+ 1930 and earlier 26 January 2021 57,146 56,34 113,486
GGD 86-90 1931-1935 29 January 2021 172,968 170,824 343,792
GGD 81-85 1936-1940 5 February 2021 360,598 356,133 716,731
GGD 76-80 1941-1945 6 March 2021 559,493 551,405 1,110,898
GGD 71-75 1946-1950 6 April 2021 849,164 829,717 1,678,881
GGD 66-70 1951-1955 19 April 2021 795,548 771,379 1,566,927
GGD 61-65 1956-1960   145,34 159,627 304,967
GGD 56-60 1961-1965 27 April 2021 1,025,114 965,823 1,990,937
GGD 51-55 1966-1970 20 May 2021 1,037,948 767,119 1,805,067
GGD 46-50 1971-1975 26 May 2021 891,344 815,724 1,707,068
GGD 41-45 1976-1980 29 May 2021 783,254 662,591 1,445,845
GGD 36-40 1981-1985 1 June 2021 759,85 676,34 1,436,190
GGD 31-35 1986-1990 7 June 2021 771,188 672,926 1,444,114
GGD 26-30 1991-1995 11 June 2021 754,881 629,885 1,384,766
GGD 18-25 1996-2003 15 June 2021 1,233,269 918,791 2,152,060
GGD 12-17 2004-2009 22 June 2021 799,725 710,57 1,510,295
GGD 5-11 2010-2016 18 January 2022 85,599 37,772 123,371
GGD Unknown Unknown   1,469 853 2,322
GPs (estimated)     15 February 2021 1,147,803 1,062,781 2,210,584
Other vaccinators (estimated)     6 January 2021 646,837 476,804 1,123,641
Total       12,878,538 11,293,404 24,171,942
  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 24, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 82,8% 81,9%
18 years and older 2003 and before 83,9% 83,2%
  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

14 June 2022 | 16:00

Vaccination figures: 6 June – 12 June 2022

Up to and including Sunday 12 June 2022, more than 2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 43.1%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered. 64.1% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 81.9% of all people over 18 years old have completed the basic series. 83.2% of all people over 12 years old have completed the basic series.


Vaccination figures: 6 January 2021 – 12 June 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 23 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 91+ 1930 and earlier 26 January 2021 57,299 56,49 113,789
GGD 86-90 1931-1935 29 January 2021 173,264 171,109 344,373
GGD 81-85 1936-1940 5 February 2021 360,899 356,428 717,327
GGD 76-80 1941-1945 6 March 2021 559,782 551,688 1,111,470
GGD 71-75 1946-1950 6 April 2021 849,429 829,976 1,679,405
GGD 66-70 1951-1955 19 April 2021 795,697 771,516 1,567,213
GGD 61-65 1956-1960   145,341 159,631 304,972
GGD 56-60 1961-1965 27 April 2021 1,025,178 965,871 1,991,049
GGD 51-55 1966-1970 20 May 2021 1,038,017 767,145 1,805,162
GGD 46-50 1971-1975 26 May 2021 891,388 815,722 1,707,110
GGD 41-45 1976-1980 29 May 2021 783,271 662,584 1,445,855
GGD 36-40 1981-1985 1 June 2021 759,866 676,338 1,436,204
GGD 31-35 1986-1990 7 June 2021 771,232 672,937 1,444,169
GGD 26-30 1991-1995 11 June 2021 754,907 629,883 1,384,790
GGD 18-25 1996-2003 15 June 2021 1,233,187 918,59 2,151,777
GGD 12-17 2004-2009 22 June 2021 799,512 710,157 1,509,669
GGD 5-11 2010-2016 18 January 2022 84,683 37,062 121,745
GGD Unknown Unknown   1,426 832 2,258
GPs (estimated)     15 February 2021 1,148,176 1,063,113 2,211,289
Other vaccinators (estimated)     6 January 2021 647,429 477,358 1,124,787
Total       12,879,983 11,294,430 24,174,413

 

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 23, 2022, by type of vaccinator.

  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 23, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 82,8% 81,9%
18 years and older 2003 and before 83,9% 83,2%

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 23, 20221-4

  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

7 June 2022 | 16:00

Vaccination figures: 30 May – 5 June 2022

Up to and including Sunday 5 June 2022, more than 2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 42.5%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered. 64% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 81.9% of all people over 18 years old have completed the basic series. 83.2% of all people over 12 years old have completed the basic series.


Vaccination figures: 6 January 2021 – 5 June 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 22 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 91+ 1930 and earlier 26 January 2021 57,467 56,657 114,124
GGD 86-90 1931-1935 29 January 2021 173,537 171,372 344,909
GGD 81-85 1936-1940 5 February 2021 361,185 356,709 717,894
GGD 76-80 1941-1945 6 March 2021 560,058 551,950 1,112,008
GGD 71-75 1946-1950 6 April 2021 849,689 830,229 1,679,918
GGD 66-70 1951-1955 19 April 2021 795,838 771,644 1,567,482
GGD 61-65 1956-1960   145,351 159,643 304,994
GGD 56-60 1961-1965 27 April 2021 1,025,259 965,946 1,991,205
GGD 51-55 1966-1970 20 May 2021 1,038,072 767,184 1,805,256
GGD 46-50 1971-1975 26 May 2021 891,404 815,724 1,707,128
GGD 41-45 1976-1980 29 May 2021 783,277 662,574 1,445,851
GGD 36-40 1981-1985 1 June 2021 759,897 676,320 1,436,217
GGD 31-35 1986-1990 7 June 2021 771,245 672,908 1,444,153
GGD 26-30 1991-1995 11 June 2021 754,923 629,856 1,384,779
GGD 18-25 1996-2003 15 June 2021 1,233,123 918,446 2,151,569
GGD 12-17 2004-2009 22 June 2021 799,323 709,854 1,509,177
GGD 5-11 2010-2016 18 January 2022 84,005 36,541 120,546
GGD Unknown Unknown   1,391 819 2,210
GPs (estimated)     15 February 2021 1,148,565 1,063,466 2,212,031
Other vaccinators (estimated)     6 January 2021 647,937 477,829 1,125,766
Total       12,881,546 11,295,671 24,177,217
  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 22, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 82,8% 81,9%
18 years and older 2003 and before 84,0% 83,2%
  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

31 May 2022 | 16:00

Vaccination figures: 23 to 29 May 2022

Up to and including Sunday 29 May, more than 2 million repeat vaccinations had been administered in the Netherlands. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 41.8%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered. 64% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 83.2% of all people over 18 years old have completed the basic series. 82% of all people over 12 years old have completed the basic series.


Vaccination figures: 6 January 2021 – 29 May 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 21 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 91+ 1930 and earlier 26 January 2021 57,662 56,849 114,511
GGD 86-90 1931-1935 29 January 2021 173,876 171,705 345,581
GGD 81-85 1936-1940 5 February 2021 361,543 357,059 718,602
GGD 76-80 1941-1945 6 March 2021 560,39 552,274 1,112,664
GGD 71-75 1946-1950 6 April 2021 850,014 830,541 1,680,555
GGD 66-70 1951-1955 19 April 2021 796,052 771,84 1,567,892
GGD 61-65 1956-1960   145,366 159,649 305,015
GGD 56-60 1961-1965 27 April 2021 1,025,363 966,036 1,991,399
GGD 51-55 1966-1970 20 May 2021 1,038,135 767,216 1,805,351
GGD 46-50 1971-1975 26 May 2021 891,485 815,769 1,707,254
GGD 41-45 1976-1980 29 May 2021 783,325 662,592 1,445,917
GGD 36-40 1981-1985 1 June 2021 759,986 676,381 1,436,367
GGD 31-35 1986-1990 7 June 2021 771,376 672,981 1,444,357
GGD 26-30 1991-1995 11 June 2021 755,064 629,947 1,385,011
GGD 18-25 1996-2003 15 June 2021 1,233,099 918,266 2,151,365
GGD 12-17 2004-2009 22 June 2021 799,075 709,578 1,508,653
GGD 5-11 2010-2016 18 January 2022 83,126 36,05 119,176
GGD Unknown Unknown   1,362 809 2,171
GPs (estimated)     15 February 2021 1,148,956 1,063,847 2,212,803
Other vaccinators (estimated)     6 January 2021 648,602 478,437 1,127,039
Total       12,883,857 11,297,826 24,181,683
  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 21, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.8% 84.9%
18 years and older 2003 and before 89.4% 86.4%
  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.

24 May 2022 | 15:15

COVID-19 vaccination figures more up-to-date due to optimised monitoring 

RIVM has been publishing national and regional figures on COVID-19 vaccination in the Netherlands every week since 19 January 2021. As of 24 May 2022, the method used to monitor vaccination figures has been optimised and population data has been updated. As a result, the figures provide a more up-to-date and accurate overview of vaccination coverage in the Dutch population. The optimisation process has resulted in adjusted vaccination coverage figures

Read the news: COVID-19 vaccination figures more up-to-date due to optimised monitoring

Vaccination figures: 6 January 2021 – 22 May 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 20 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 91+ 1930 and earlier 26 January 2021 57,808 56,994 114,802
GGD 86-90 1931-1935 29 January 2021 174,11 171,931 346,041
GGD 81-85 1936-1940 5 February 2021 361,824 357,335 719,159
GGD 76-80 1941-1945 6 March 2021 560,632 552,514 1,113,146
GGD 71-75 1946-1950 6 April 2021 850,239 830,761 1,681,000
GGD 66-70 1951-1955 19 April 2021 796,165 771,949 1,568,114
GGD 61-65 1956-1960   145,377 159,646 305,023
GGD 56-60 1961-1965 27 April 2021 1,025,436 966,112 1,991,548
GGD 51-55 1966-1970 20 May 2021 1,038,152 767,223 1,805,375
GGD 46-50 1971-1975 26 May 2021 891,495 815,767 1,707,262
GGD 41-45 1976-1980 29 May 2021 783,327 662,572 1,445,899
GGD 36-40 1981-1985 1 June 2021 759,989 676,378 1,436,367
GGD 31-35 1986-1990 7 June 2021 771,383 672,978 1,444,361
GGD 26-30 1991-1995 11 June 2021 755,058 629,929 1,384,987
GGD 18-25 1996-2003 15 June 2021 1,232,990 918,114 2,151,104
GGD 12-17 2004-2009 22 June 2021 798,812 709,291 1,508,103
GGD 5-11 2010-2016 18 January 2022 82,092 35,521 117,613
GGD Unknown Unknown   1,341 798 2,139
GPs (estimated)     15 February 2021 1,149,244 1,064,132 2,213,376
Other vaccinators (estimated)     6 January 2021 649,128 478,922 1,128,050
Total       12,884,602 11,298,867 24,183,469

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 20, 2022, by type of vaccinator.

  1. Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
  2. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  3. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  4. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  5. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 20, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.8% 84.9%
18 years and older 2003 and before 89.4% 86.4%

Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 20, 20221-4

  1. Source: CIMS+ methode
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 

17 May 2022 | 16:15

Vaccination figures: 9 to 15 May 2022

Up to and including Sunday 15 May, more than 1.9 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 39.9%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.2 million booster jabs have been administered. 64.2% of all people over 18 have received a booster jab. 59.5% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 15 May 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 19 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,804 67,268 136,072
GGD 86-90 1931-1935 29 January 2021 190,456 187,581 378,037
GGD 81-85 1936-1940 5 February 2021 379,299 374,543 753,842
GGD 76-80 1941-1945 6 March 2021 576,178 568,161 1,144,339
GGD 71-75 1946-1950 6 April 2021 864,03 844,617 1,708,647
GGD 66-70 1951-1955 19 April 2021 805,884 780,892 1,586,776
GGD 61-65 1956-1960   150,216 164,226 314,442
GGD 56-60 1961-1965 27 April 2021 1,036,764 976,533 2,013,297
GGD 51-55 1966-1970 20 May 2021 1,050,188 777,001 1,827,189
GGD 46-50 1971-1975 26 May 2021 903,836 826,366 1,730,202
GGD 41-45 1976-1980 29 May 2021 796,281 673,513 1,469,794
GGD 36-40 1981-1985 1 June 2021 774,661 689,701 1,464,362
GGD 31-35 1986-1990 7 June 2021 788,598 688,965 1,477,563
GGD 26-30 1991-1995 11 June 2021 775,15 648,505 1,423,655
GGD 18-25 1996-2003 15 June 2021 1,255,197 940,844 2,196,041
GGD 12-17 2004-2009 22 June 2021 804,725 724,281 1,529,006
GGD 5-113 2010-2016 18 January 2022 81,585 35,095 116,68
GGD Unknown Unknown   4,211 3,094 7,305
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,472,817 11,542,904 25,015,721

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 19, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,788 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 19, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.8% 84.9%
18 years and older 2003 and before 89.4% 86.4%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 19, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. 
    The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

11 May 2022 | 8:30

Vaccination figures: 2 to 8 May 2022

Up to and including Sunday 8 May, more than 1.8 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 38.9%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered by now. 64.2% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 8 May 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 18 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,803 67,267 136,07
GGD 86-90 1931-1935 29 January 2021 190,454 187,578 378,032
GGD 81-85 1936-1940 5 February 2021 379,292 374,535 753,827
GGD 76-80 1941-1945 6 March 2021 576,169 568,148 1,144,317
GGD 71-75 1946-1950 6 April 2021 864,015 844,599 1,708,614
GGD 66-70 1951-1955 19 April 2021 805,865 780,876 1,586,741
GGD 61-65 1956-1960   150,193 164,191 314,384
GGD 56-60 1961-1965 27 April 2021 1,036,727 976,498 2,013,225
GGD 51-55 1966-1970 20 May 2021 1,050,150 776,968 1,827,118
GGD 46-50 1971-1975 26 May 2021 903,801 826,309 1,730,110
GGD 41-45 1976-1980 29 May 2021 796,238 673,454 1,469,692
GGD 36-40 1981-1985 1 June 2021 774,596 689,619 1,464,215
GGD 31-35 1986-1990 7 June 2021 788,507 688,873 1,477,380
GGD 26-30 1991-1995 11 June 2021 775,04 648,373 1,423,413
GGD 18-25 1996-2003 15 June 2021 1,255,001 940,616 2,195,617
GGD 12-17 2004-2009 22 June 2021 804,483 724,082 1,528,565
GGD 5-113 2010-2016 18 January 2022 80,7 34,627 115,327
GGD Unknown Unknown   4,204 3,105 7,309
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,470,992 11,541,436 25,012,428

 

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 18, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,720 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 18, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.8% 84.9%
18 years and older 2003 and before 89.4% 86.4%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 18, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. 
    The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated. 

03 May 2022 | 16:00

Vaccination figures: 25 April to 1 May 2022

Up to and including Sunday 1 May, more than 1.8 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 37.7%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered by now. 64% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 1 May 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 17 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,803 67,266 136,069
GGD 86-90 1931-1935 29 January 2021 190,453 187,576 378,029
GGD 81-85 1936-1940 5 February 2021 379,29 374,531 753,821
GGD 76-80 1941-1945 6 March 2021 576,156 568,134 1,144,290
GGD 71-75 1946-1950 6 April 2021 863,999 844,585 1,708,584
GGD 66-70 1951-1955 19 April 2021 805,844 780,856 1,586,700
GGD 61-65 1956-1960   150,17 164,162 314,332
GGD 56-60 1961-1965 27 April 2021 1,036,703 976,465 2,013,168
GGD 51-55 1966-1970 20 May 2021 1,050,125 776,922 1,827,047
GGD 46-50 1971-1975 26 May 2021 903,766 826,268 1,730,034
GGD 41-45 1976-1980 29 May 2021 796,192 673,399 1,469,591
GGD 36-40 1981-1985 1 June 2021 774,526 689,548 1,464,074
GGD 31-35 1986-1990 7 June 2021 788,433 688,777 1,477,210
GGD 26-30 1991-1995 11 June 2021 774,952 648,242 1,423,194
GGD 18-25 1996-2003 15 June 2021 1,254,804 940,36 2,195,164
GGD 12-17 2004-2009 22 June 2021 804,272 723,76 1,528,032
GGD 5-113 2010-2016 18 January 2022 79,73 34,124 113,854
GGD Unknown Unknown   4,195 3,103 7,298
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,469,167 11,539,796 25,008,963

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 17, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,647 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 17, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.8% 84.9%
18 years and older 2003 and before 89.4% 86.4%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 17, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. 
    The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

26 April 2022 | 16:00

Vaccination figures 18-24 April 2022

Up to and including Sunday 24 April, more than 1.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 35.8%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered by now. 63.9% of all people over 18 have received a booster jab. 59.2% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 24 April 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 16 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,803 67,265 136,068
GGD 86-90 1931-1935 29 January 2021 190,453 187,576 378,029
GGD 81-85 1936-1940 5 February 2021 379,286 374,527 753,813
GGD 76-80 1941-1945 6 March 2021 576,15 568,123 1,144,273
GGD 71-75 1946-1950 6 April 2021 863,985 844,566 1,708,551
GGD 66-70 1951-1955 19 April 2021 805,824 780,842 1,586,666
GGD 61-65 1956-1960   150,144 164,133 314,277
GGD 56-60 1961-1965 27 April 2021 1,036,678 976,426 2,013,104
GGD 51-55 1966-1970 20 May 2021 1,050,093 776,861 1,826,954
GGD 46-50 1971-1975 26 May 2021 903,743 826,22 1,729,963
GGD 41-45 1976-1980 29 May 2021 796,154 673,348 1,469,502
GGD 36-40 1981-1985 1 June 2021 774,481 689,48 1,463,961
GGD 31-35 1986-1990 7 June 2021 788,36 688,674 1,477,034
GGD 26-30 1991-1995 11 June 2021 774,863 648,121 1,422,984
GGD 18-25 1996-2003 15 June 2021 1,254,649 940,14 2,194,789
GGD 12-17 2004-2009 22 June 2021 804,039 723,483 1,527,522
GGD 5-113 2010-2016 18 January 2022 79,077 33,65 112,727
GGD Unknown Unknown   4,202 3,103 7,305
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,467,738 11,538,256 25,005,994

 

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 15, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,588 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 16, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.8% 84.9%
18 years and older 2003 and before 89.4% 86.4%

 

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 15, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. 
    The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

19 April 2022 | 16:00

Vaccination figures 11-17 April 2022

Up to and including Sunday 17 April, more than 1.5 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has reached 32.7%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered by now. 63.8% of all people over 18 have received a booster jab. 59.1% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 17 April 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 15 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,801 67,261 136,062
GGD 86-90 1931-1935 29 January 2021 190,45 187,571 378,021
GGD 81-85 1936-1940 5 February 2021 379,281 374,522 753,803
GGD 76-80 1941-1945 6 March 2021 576,143 568,116 1,144,259
GGD 71-75 1946-1950 6 April 2021 863,975 844,545 1,708,520
GGD 66-70 1951-1955 19 April 2021 805,802 780,811 1,586,613
GGD 61-65 1956-1960   150,114 164,099 314,213
GGD 56-60 1961-1965 27 April 2021 1,036,657 976,389 2,013,046
GGD 51-55 1966-1970 20 May 2021 1,050,062 776,819 1,826,881
GGD 46-50 1971-1975 26 May 2021 903,701 826,166 1,729,867
GGD 41-45 1976-1980 29 May 2021 796,124 673,289 1,469,413
GGD 36-40 1981-1985 1 June 2021 774,43 689,407 1,463,837
GGD 31-35 1986-1990 7 June 2021 788,285 688,552 1,476,837
GGD 26-30 1991-1995 11 June 2021 774,783 647,987 1,422,770
GGD 18-25 1996-2003 15 June 2021 1,254,462 939,864 2,194,326
GGD 12-17 2004-2009 22 June 2021 803,86 723,164 1,527,024
GGD 5-113 2010-2016 18 January 2022 78,252 32,553 110,805
GGD Unknown Unknown   4,205 3,098 7,303
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,466,141 11,535,931 25,002,072

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 15, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,533 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 15, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 15, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. 
    The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

12 April 2022 | 16:00

Vaccination figures 4-10 April 2022

Up to and including Sunday 10 April, more than 1.3 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has reached 28.5%.

Numbers and vaccination coverage for COVID-19 booster vaccination

More than 9.1 million booster jabs have been administered by now. 63.6% of all people over 18 have received a booster jab. 58.9% of all people over 12 have received a booster jab.

Numbers and vaccination coverage for basic series of COVID-19 vaccinations

It is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 10 April 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 14 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,801 67,261 136,062
GGD 86-90 1931-1935 29 January 2021 190,448 187,566 378,014
GGD 81-85 1936-1940 5 February 2021 379,277 374,518 753,795
GGD 76-80 1941-1945 6 March 2021 576,131 568,103 1,144,234
GGD 71-75 1946-1950 6 April 2021 863,962 844,524 1,708,486
GGD 66-70 1951-1955 19 April 2021 805,775 780,781 1,586,556
GGD 61-65 1956-1960   150,079 164,07 314,149
GGD 56-60 1961-1965 27 April 2021 1,036,624 976,347 2,012,971
GGD 51-55 1966-1970 20 May 2021 1,050,032 776,751 1,826,783
GGD 46-50 1971-1975 26 May 2021 903,663 826,09 1,729,753
GGD 41-45 1976-1980 29 May 2021 796,067 673,2 1,469,267
GGD 36-40 1981-1985 1 June 2021 774,378 689,295 1,463,673
GGD 31-35 1986-1990 7 June 2021 788,19 688,41 1,476,600
GGD 26-30 1991-1995 11 June 2021 774,685 647,838 1,422,523
GGD 18-25 1996-2003 15 June 2021 1,254,300 939,561 2,193,861
GGD 12-17 2004-2009 22 June 2021 803,681 722,755 1,526,436
GGD 5-113 2010-2016 18 January 2022 77,466 30,899 108,365
GGD Unknown Unknown   4,222 3,098 7,32
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,464,535 11,532,785 24,997,320

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 14, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,453 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 14, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 14, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. 
    The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

5 April 2022 | 16:00

Vaccination figures: 28 March to 3 April 2022

Up to and including Sunday 3 April, more than 1 million repeat vaccinations had been administered in the Netherlands. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19. They can get the repeat vaccination 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. As of this week, this report also includes vaccination coverage and the graph by age for the repeat vaccination against COVID-19. Vaccination coverage for the repeat vaccination among people over 60 has reached 22.4%.

Numbers and vaccination coverage for the booster vaccination

More than 9 million booster vaccinations have been given by now. 63.4% of all people over 18 have received a booster vaccination. 58.7% of all people over 12 have received a booster vaccination.

Numbers and vaccination coverage for the basic series

It is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Vaccination figures: 6 January 2021 – 3 April 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 13 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,799 67,257 136,056
GGD 86-90 1931-1935 29 January 2021 190,447 187,563 378,01
GGD 81-85 1936-1940 5 February 2021 379,268 374,508 753,776
GGD 76-80 1941-1945 6 March 2021 576,117 568,084 1,144,201
GGD 71-75 1946-1950 6 April 2021 863,942 844,481 1,708,423
GGD 66-70 1951-1955 19 April 2021 805,756 780,744 1,586,500
GGD 61-65 1956-1960   150,058 164,01 314,068
GGD 56-60 1961-1965 27 April 2021 1,036,596 976,278 2,012,874
GGD 51-55 1966-1970 20 May 2021 1,049,983 776,679 1,826,662
GGD 46-50 1971-1975 26 May 2021 903,625 826,003 1,729,628
GGD 41-45 1976-1980 29 May 2021 796,008 673,098 1,469,106
GGD 36-40 1981-1985 1 June 2021 774,315 689,159 1,463,474
GGD 31-35 1986-1990 7 June 2021 788,103 688,25 1,476,353
GGD 26-30 1991-1995 11 June 2021 774,587 647,641 1,422,228
GGD 18-25 1996-2003 15 June 2021 1,254,101 939,191 2,193,292
GGD 12-17 2004-2009 22 June 2021 803,502 722,202 1,525,704
GGD 5-113 2010-2016 18 January 2022 76,777 27,476 104,253
GGD Unknown Unknown   4,231 3,085 7,316
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,462,969 11,527,427 24,990,396

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 13, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,401 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 13, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%

 Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 13, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. 
    The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

29 March 2022 | 16:15

Vaccination figures 21 to 27 March 2022

As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. As of 26 March, this option is available to people aged 60 years and older. Up to and including Sunday 27 March, more than 725,000 repeat vaccinations had been administered.

Numbers and vaccination coverage for the basic series

By Sunday 27 March 2022, it is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.
It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Numbers and vaccination coverage for the booster vaccination

By now, more than 8.9 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.
62.8% of all people over 18 have received a booster vaccination. 58.1% of all people over 12 have received a booster vaccination.

Vaccination figures: 6 January 2021 – 27 March 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 12 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,795 67,252 136,047
GGD 86-90 1931-1935 29 January 2021 190,443 187,558 378,001
GGD 81-85 1936-1940 5 February 2021 379,257 374,49 753,747
GGD 76-80 1941-1945 6 March 2021 576,092 568,06 1,144,152
GGD 71-75 1946-1950 6 April 2021 863,912 844,453 1,708,365
GGD 66-70 1951-1955 19 April 2021 805,728 780,711 1,586,439
GGD 61-65 1956-1960   150,03 163,97 314
GGD 56-60 1961-1965 27 April 2021 1,036,553 976,232 2,012,785
GGD 51-55 1966-1970 20 May 2021 1,049,938 776,625 1,826,563
GGD 46-50 1971-1975 26 May 2021 903,599 825,935 1,729,534
GGD 41-45 1976-1980 29 May 2021 795,971 673,008 1,468,979
GGD 36-40 1981-1985 1 June 2021 774,253 689,06 1,463,313
GGD 31-35 1986-1990 7 June 2021 788,013 688,101 1,476,114
GGD 26-30 1991-1995 11 June 2021 774,495 647,451 1,421,946
GGD 18-25 1996-2003 15 June 2021 1,253,925 938,863 2,192,788
GGD 12-17 2004-2009 22 June 2021 803,544 721,807 1,525,351
GGD 5-113 2010-2016 18 January 2022 76,093 19,469 95,562
GGD Unknown Unknown   4,469 3,207 7,676
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,461,864 11,517,970 24,979,834

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 12, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,355 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 12, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 12, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

22 March 2022 | 16:30

Vaccination figures 14 to 20 March 2022

As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. Up to and including Sunday 20 March, 429,000 repeat vaccinations had been administered. 

Numbers and vaccination coverage for the basic series

By Sunday 20 March 2022, it is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Numbers and vaccination coverage for the booster vaccination

By now, more than 8.9 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.

62.6% of all people over 18 have received a booster vaccination. 57.9% of all people over 12 have received a booster vaccination.

Vaccination figures: 6 January 2021 – 20 March 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 11 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,794 67,248 136,042
GGD 86-90 1931-1935 29 January 2021 190,441 187,553 377,994
GGD 81-85 1936-1940 5 February 2021 379,251 374,485 753,736
GGD 76-80 1941-1945 6 March 2021 576,076 568,039 1,144,115
GGD 71-75 1946-1950 6 April 2021 863,892 844,423 1,708,315
GGD 66-70 1951-1955 19 April 2021 805,699 780,672 1,586,371
GGD 61-65 1956-1960   149,983 163,934 313,917
GGD 56-60 1961-1965 27 April 2021 1,036,498 976,177 2,012,675
GGD 51-55 1966-1970 20 May 2021 1,049,885 776,552 1,826,437
GGD 46-50 1971-1975 26 May 2021 903,54 825,856 1,729,396
GGD 41-45 1976-1980 29 May 2021 795,903 672,893 1,468,796
GGD 36-40 1981-1985 1 June 2021 774,146 688,914 1,463,060
GGD 31-35 1986-1990 7 June 2021 787,873 687,896 1,475,769
GGD 26-30 1991-1995 11 June 2021 774,364 647,22 1,421,584
GGD 18-25 1996-2003 15 June 2021 1,253,741 938,512 2,192,253
GGD 12-17 2004-2009 22 June 2021 803,368 721,416 1,524,784
GGD 5-113 2010-2016 18 January 2022 75,052 4,467 79,519
GGD Unknown Unknown   4,476 3,199 7,675
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,459,736 11,501,174 24,960,910
  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,302 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 11, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

15 March 2022 | 16:50

Vaccination figures 7 March to 13 March 2022

As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. Up to and including Sunday 13 March, 178,300 repeat vaccinations had been administered. 

Numbers and vaccination coverage for the basic series

By Sunday 13 March 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Numbers and vaccination coverage for the booster vaccination

By now, more than 8.9 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.

62.4% of all people over 18 have received a booster vaccination. As of last week, young people aged 12-18 years can also get a booster vaccination. 57.7% of all people over 12 have received a booster vaccination.

Vaccination figures: 6 January 2021 – 13 March 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 10 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,789 67,244 136,033
GGD 86-90 1931-1935 29 January 2021 190,433 187,544 377,977
GGD 81-85 1936-1940 5 February 2021 379,238 374,469 753,707
GGD 76-80 1941-1945 6 March 2021 576,053 568,024 1,144,077
GGD 71-75 1946-1950 6 April 2021 863,852 844,398 1,708,250
GGD 66-70 1951-1955 19 April 2021 805,652 780,637 1,586,289
GGD 61-65 1956-1960   149,908 163,893 313,801
GGD 56-60 1961-1965 27 April 2021 1,036,426 976,097 2,012,523
GGD 51-55 1966-1970 20 May 2021 1,049,814 776,466 1,826,280
GGD 46-50 1971-1975 26 May 2021 903,455 825,763 1,729,218
GGD 41-45 1976-1980 29 May 2021 795,827 672,809 1,468,636
GGD 36-40 1981-1985 1 June 2021 774,037 688,76 1,462,797
GGD 31-35 1986-1990 7 June 2021 787,735 687,684 1,475,419
GGD 26-30 1991-1995 11 June 2021 774,203 646,963 1,421,166
GGD 18-25 1996-2003 15 June 2021 1,253,523 938,126 2,191,649
GGD 12-17 2004-2009 22 June 2021 803,182 721,117 1,524,299
GGD 5-113 2010-2016 18 January 2022 74,402 1,057 75,459
GGD Unknown Unknown   4,527 3,251 7,778
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,457,810 11,496,020 24,953,830
  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,258 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 10, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

8 March 2022 | 16:30

Vaccination figures 28 February 2022 to 6 March 2022

Numbers and vaccination coverage for the basic series

By Sunday 6 March 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Numbers and vaccination coverage for the booster vaccination

By now, more than 8.8 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.

62.0% of all people over 18 have now received a booster vaccination. 

Vaccination figures: 6 January 2021 – 6 March 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 9 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,788 67,236 136,024
GGD 86-90 1931-1935 29 January 2021 190,430 187,531 377,961
GGD 81-85 1936-1940 5 February 2021 379,221 374,441 753,662
GGD 76-80 1941-1945 6 March 2021 576,032 567.988 1,144,020
GGD 71-75 1946-1950 6 April 2021 863,821 844,341 1,708,162
GGD 66-70 1951-1955 19 April 2021 805,629 780,595 1,586,223
GGD 61-65 1956-1960   149,876 163,832 313,708
GGD 56-60 1961-1965 27 April 2021 1,036,389 976,031 2,012,420
GGD 51-55 1966-1970 20 May 2021 1,049,762 776,378 1,826,140
GGD 46-50 1971-1975 26 May 2021 903,415 825,641 1,729,056
GGD 41-45 1976-1980 29 May 2021 795,782 672,695 1,468,477
GGD 36-40 1981-1985 1 June 2021 773,952 688,573 1,462,525
GGD 31-35 1986-1990 7 June 2021 787,626 687,454 1,475,080
GGD 26-30 1991-1995 11 June 2021 774,063 646,627 1,420,690
GGD 18-25 1996-2003 15 June 2021 1,253,314 937,628 2,190,942
GGD 12-17 2004-2009 22 June 2021 803,003 720,750 1,523,753
GGD 5-113 2010-2016 18 January 2022 73,803 925 74,728
GGD Unknown Unknown   4,590 3,319 7,909
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,456,250 11,493,702 24,949,952

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 8, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,147 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 9, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 9, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

1 March 2022 | 16:00

Vaccination figures 21 to 27 February 2021

Number of vaccinations in the basic series

By Sunday 27 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. About 13.5 million of those were first vaccinations, and nearly 11.5 million were second vaccinations.  More than 133,000 third vaccinations were administered to people with severely impaired immunity. 

Vaccination coverage for the basic series

It is estimated that 89.4% of all people over 18 have received at least one vaccination in the basic series, and 86.4% have completed the basic series. According to estimates, 87.7% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.9% have completed the basic series.

Number of booster vaccinations

By now, more than 8.8 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.

Vaccination coverage for the booster vaccination

61.9% of all people over 18 have now received a booster vaccination. 
 

Vaccination figures: 6 January 2021 – 27 February 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 8 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total4
GGD 91+ 1930 and earlier 26 January 2021 68,783 67,226 136,009
GGD 86-90 1931-1935 29 January 2021 190,424 187,521 377,945
GGD 81-85 1936-1940 5 February 2021 379,212 374,416 753,628
GGD 76-80 1941-1945 6 March 2021 576,022 567,958 1,143,980
GGD 71-75 1946-1950 6 April 2021 863,804 844,305 1,708,109
GGD 66-70 1951-1955 19 April 2021 805,59 780,542 1,586,132
GGD 61-65 1956-1960   149,842 163,754 313,596
GGD 56-60 1961-1965 27 April 2021 1,036,346 975,921 2,012,267
GGD 51-55 1966-1970 20 May 2021 1,049,708 776,236 1,825,944
GGD 46-50 1971-1975 26 May 2021 903,351 825,5 1,728,851
GGD 41-45 1976-1980 29 May 2021 795,682 672,524 1,468,206
GGD 36-40 1981-1985 1 June 2021 773,841 688,301 1,462,142
GGD 31-35 1986-1990 7 June 2021 787,461 687,086 1,474,547
GGD 26-30 1991-1995 11 June 2021 773,861 646,179 1,420,040
GGD 18-25 1996-2003 15 June 2021 1,253,031 936,973 2,190,004
GGD 12-17 2004-2009 22 June 2021 802,766 720,202 1,522,968
GGD 5-113 2010-2016 18 January 2022 72,955 752 73,707
GGD Unknown Unknown   4,597 3,357 7,954
GPs (estimated)5,6,7     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)5,6,8     6 January 2021 940,525 482,801 1,423,326
Total8       13,454,030 11,490,471 24,944,501
  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
  5. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  6. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  7. 222,356 estimated vaccinations administered by other vaccinators, and 646,147 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  8. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 8, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

22 February 2022 | 16:00

Vaccination figures 14 to 20 February 2021

Number of vaccinations in the basic series

By Sunday 20 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  More than 133,000 third vaccinations were administered to people with severely impaired immunity. 

Vaccination coverage for the basic series

It is estimated that 89.4% of all people over 18 have received at least one vaccination in the basic series, and 86.4% have completed the basic series. According to estimates, 87.7% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.9% have completed the basic series.

Number of booster vaccinations

By now, nearly 8.8 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.

Vaccination coverage for the booster vaccination

61.5% of all people over 18 have now received a booster vaccination. 
 

Vaccination figures: 6 January 2021 – 20 February 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 7 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,777 67,213 135,99
GGD 86-90 1931-1935 29 January 2021 190,416 187,505 377,921
GGD 81-85 1936-1940 5 February 2021 379,199 374,391 753,59
GGD 76-80 1941-1945 6 March 2021 576,002 567,916 1,143,918
GGD 71-75 1946-1950 6 April 2021 863,781 844,243 1,708,024
GGD 66-70 1951-1955 19 April 2021 805,558 780,483 1,586,041
GGD 61-65 1956-1960   149,812 163,682 313,494
GGD 56-60 1961-1965 27 April 2021 1,036,287 975,782 2,012,069
GGD 51-55 1966-1970 20 May 2021 1,049,645 776,079 1,825,724
GGD 46-50 1971-1975 26 May 2021 903,293 825,323 1,728,616
GGD 41-45 1976-1980 29 May 2021 795,602 672,324 1,467,926
GGD 36-40 1981-1985 1 June 2021 773,752 688,046 1,461,798
GGD 31-35 1986-1990 7 June 2021 787,287 686,629 1,473,916
GGD 26-30 1991-1995 11 June 2021 773,685 645,64 1,419,325
GGD 18-25 1996-2003 15 June 2021 1,252,756 936,214 2,188,970
GGD 12-17 2004-2009 22 June 2021 802,49 719,461 1,521,951
GGD 5-113 2010-2016 18 January 2022 71,711 507 72,218
GGD Unknown Unknown   4,639 3,407 8,046
GPs (estimated)4,5,6     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)4,5,7     6 January 2021 940,525 482,801 1,423,326
Total7       13,451,446 11,486,563 24,938,009
  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  5. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  6. 222,356 estimated vaccinations administered by other vaccinators, and 646,102 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 7, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.9%
18 years and older 2003 and before 89.4% 86.4%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

18 February 2022 | 17:00

Vaccination figures 7 to 13 February 2021

Number of vaccinations in the basic series

By Sunday 13 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  About 133,000 third vaccinations have been administered to people with severely impaired immunity.

Vaccination coverage for the basic series

It is estimated that 89.3% of all people over 18 have received at least one vaccination in the basic series, and 86.4% have completed the basic series. According to estimates, 87.7% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.8% have completed the basic series.

Number of booster vaccinations

By now, more than 8.7 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service. Over 118,000 booster vaccinations were administered last week. 

Vaccination coverage for the booster vaccination

61.1% of all people over 18 have now received a booster vaccination. Booster vaccination coverage increased by 1% in almost all age groups. As with the basic series, booster vaccination coverage is higher among older people than among young people. 

As of this week, booster vaccination coverage among people over 18 is now available in a map at the level of the municipalities. Separate maps are also provided for the age groups of 18 to 59 years and of 60 years and older. The pattern of booster vaccination coverage per municipality is similar to that of the basic series.  Vaccination coverage is somewhat higher in the east of the Netherlands than in the west.  In the Randstad region along the west coast, booster vaccination coverage is somewhat lower in a number of larger cities than in the surrounding municipalities. 
 

Vaccination figures: 6 January 2021 – 13 February 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 6 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,775 67,203 135,978
GGD 86-90 1931-1935 29 January 2021 190,407 187,489 377,896
GGD 81-85 1936-1940 5 February 2021 379,18 374,363 753,543
GGD 76-80 1941-1945 6 March 2021 575,972 567,872 1,143,844
GGD 71-75 1946-1950 6 April 2021 863,752 844,179 1,707,931
GGD 66-70 1951-1955 19 April 2021 805,525 780,379 1,585,904
GGD 61-65 1956-1960   149,762 163,576 313,338
GGD 56-60 1961-1965 27 April 2021 1,036,199 975,606 2,011,805
GGD 51-55 1966-1970 20 May 2021 1,049,556 775,86 1,825,416
GGD 46-50 1971-1975 26 May 2021 903,178 825,079 1,728,257
GGD 41-45 1976-1980 29 May 2021 795,442 672,02 1,467,462
GGD 36-40 1981-1985 1 June 2021 773,504 687,604 1,461,108
GGD 31-35 1986-1990 7 June 2021 786,957 685,927 1,472,884
GGD 26-30 1991-1995 11 June 2021 773,341 644,817 1,418,158
GGD 18-25 1996-2003 15 June 2021 1,252,236 934,962 2,187,198
GGD 12-17 2004-2009 22 June 2021 802,148 718,352 1,520,500
GGD 5-113 2010-2016 18 January 2022 69,683 254 69,937
GGD Unknown Unknown   4,671 3,471 8,142
GPs (estimated)4,5,6     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)4,5,7     6 January 2021 940,525 482,801 1,423,326
Total7       13,447,042 11,480,731 24,927,773
  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVMNational Institute for Public Health and the Environment. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  5. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  6. 222,356 estimated vaccinations administered by other vaccinators, and 646,073 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 6, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.7% 84.8%
18 years and older 2003 and before 89.3% 86.4%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

8 February 2022 | 16:00

Vaccination figures: 31 January 2022 to 6 February 2022

Number of vaccinations in the basic series

By Sunday 6 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  About 133,000 third vaccinations have been administered to people with severely impaired immunity. 

Vaccination coverage for the basic series

It is estimated that 89.3% of all people over 18 have received at least one vaccination in the basic series, and 86.3% have completed the basic series. According to estimates, 87.6% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.8% have completed the basic series.

Number of booster vaccinations

By now, more than 8.6 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.

Vaccination coverage for the booster vaccination

60.2% of all people over 18 have now received a booster vaccination.

Vaccination figures: 6 January 2021 – 6 February 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 5 (2022), by type of vaccinator.

Target group Birth year Start date2 First dose Second dose3 Total
91+ 1930 and earlier 26 January 2021 68,766 67,188 135,954
86-90 1931-1935 29 January 2021 190,400 187,462 377,862
81-85 1936-1940 5 February 2021 379,154 374,306 753,460
76-80 1941-1945 6 March 2021 575,939 567,816 1,143,755
71-75 1946-1950 6 April 2021 863,695 844,083 1,707,778
66-70 1951-1955 19 April 2021 805,465 780,250 1,585,715
61-65 1956-1960   149,681 163,434 313,115
56-60 1961-1965 27 April 2021 1,036,069 975,314 2,011,383
51-55 1966-1970 20 May 2021 1,049,377 775,493 1,824,870
46-50 1971-1975 26 May 2021 902,994 824,720 1,727,714
41-45 1976-1980 29 May 2021 795,204 671,531 1,466,735
36-40 1981-1985 1 June 2021 773,132 686,965 1,460,097
31-35 1986-1990 7 June 2021 786,480 684,957 1,471,437
26-30 1991-1995 11 June 2021 772,702 643,627 1,416,329
18-25 1996-2003 15 June 2021 1,251,172 932,819 2,183,991
12-17 2004-2009 22 June 2021 801,323 715,960 1,517,283
5-113 2010-2016 18 January 2022 64,829 0 64,829
Unknown Unknown   4,757 3,591 8,348
    15 February 2021 1,226,229 1,088,917 2,315,146
    6 January 2021 940,525 482,801 1,423,326
      13,437,893 11,471,234 24,909,127
  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVMNational Institute for Public Health and the Environment. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  5. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  6. 222,356 estimated vaccinations administered by other vaccinators, and 645,975 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 5, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.6% 84.8%
18 years and older 2003 and before 89.3% 86.3%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

2 February 2022 | 16:00

Vaccination figures: 24 to 30 January 2022 

Number of vaccinations in the basic series

By Sunday 30 January 2022, it is estimated that more than 24.8 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  Nearly 133,000 third vaccinations have been administered to people with severely impaired immunity.  

As of this week, the age group of 5-11 years is now included in the turnout for the first vaccination and vaccination coverage for the basic series. First vaccinations continue to be administered in all age groups. In this week, that gradual trend can primarily be observed in vaccination turnout among the age groups of 18-25 years and 86-90 years (+1%). 

Vaccination coverage for the basic series

It is estimated that 89.3% of all people over 18 have received at least one vaccination in the basic series, and 86.3% have completed the basic series. According to estimates, 87.6% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.7% have completed the basic series.

Number of booster vaccinations

More than 8.4 million booster vaccinations have been administered by now. More than 7.4 million of these were administered by Municipal Public Health Services (GGDs). Other vaccinators, such as hospitals, GPs or care institutions that have their own medical service, have administered more than 951,000 booster vaccinations.* 

Vaccination coverage for the booster vaccination

58.8% of all people over 18 have now received a booster vaccination, a 2.2% increase compared to last week.  The increase is highest in the younger age groups.  

* As of 1 February 2022, the number of booster vaccinations is based on vaccinations registered by the GGD, supplemented by booster vaccinations registered in CIMS (COVID Vaccination Information and Monitoring System) by other vaccinators than the GGD. Estimates are no longer used for the booster vaccinations.
 

Vaccination figures: 6 January 2021 – 30 January 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 4 (2022), by type of vaccinator.

Target group Birth year Start date2 First dose Second dose3 Total
91+ 1930 and earlier 26 January 2021 68,758 67,179 135,937
86-90 1931-1935 29 January 2021 190,389 187,439 377,828
81-85 1936-1940 5 February 2021 379,120 374,249 753,369
76-80 1941-1945 6 March 2021 575,877 567,740 1,143,617
71-75 1946-1950 6 April 2021 863,605 843,972 1,707,577
66-70 1951-1955 19 April 2021 805,366 780,092 1,585,458
61-65 1956-1960   149,582 163,239 312,821
56-60 1961-1965 27 April 2021 1,035,875 974,930 2,010,805
51-55 1966-1970 20 May 2021 1,049,139 775,021 1,824,160
46-50 1971-1975 26 May 2021 902,761 824,210 1,726,971
41-45 1976-1980 29 May 2021 794,930 670,924 1,465,854
36-40 1981-1985 1 June 2021 772,719 686,188 1,458,907
31-35 1986-1990 7 June 2021 785,811 683,819 1,469,630
26-30 1991-1995 11 June 2021 771,916 642,142 1,414,058
18-25 1996-2003 15 June 2021 1,249,737 929,913 2,179,650
12-17 2004-2009 22 June 2021 800,062 712,467 1,512,529
5-113 2010-2016 18 January 2022 52,047 351 52,398
Unknown Unknown   4,945 3,812 8,757
    15 February 2021 1,226,229 1,088,917 2,315,146
    6 January 2021 940,525 482,801 1,423,326
      13,419,393 11,459,405 24,878,798
  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVMNational Institute for Public Health and the Environment. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
  4. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  5. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  6. 222,356 estimated vaccinations administered by other vaccinators, and 645,877 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 4, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.6% 84.7%
18 years and older 2003 and before 89.3% 86.3%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
  4. The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

25 January 2022 | 16:45

Vaccination figures: 17 to 23 January 2022 

Number of vaccinations in the basic series

By Sunday 23 January 2022, it is estimated that more than 24.8 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  In addition, nearly 133,000 third vaccinations were administered to people with severely impaired immunity. 

Vaccination coverage for the basic series

It is estimated that 89.2% of all people over 18 have received at least one vaccination in the basic series, and 86.2% have completed the basic series. According to estimates, 87.6% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.7% have completed the basic series.

Number of booster vaccinations

More than 8 million booster vaccinations have been administered by now. More than 7.2 million of these were administered by Municipal Public Health Services (GGDs). It is estimated that other vaccinators, such as hospitals, GPs or care institutions that have their own medical service, have administered 859,000 booster vaccinations.

Vaccination coverage for the booster vaccination

It is estimated that 56.6% of all people over 18 have now received a booster vaccination. As of this week, we are also providing updates on booster vaccination coverage by age. Booster vaccination coverage is highest in older age groups. These age groups were the first to be invited for the booster vaccination. 

Vaccination turnout among the age groups is rising faster for the booster vaccination than it did for the basic series. This is because the pace of vaccination is much faster for the booster. Vaccination coverage for the booster vaccination is currently much lower than vaccination coverage for the basic series of COVID-19 vaccinations. This is partly because the basic series must have been completed at least 3 months ago before a booster vaccination is administered. This is also partly because many people recently had COVID-19 and then have to wait three months before they can get a booster vaccination. 
 

Vaccination figures: 6 January 2021 – 23 January 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 3 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,747 67,166 135,913
GGD 86-90 1931-1935 29 January 2021 190,360 187,404 377,764
GGD 81-85 1936-1940 5 February 2021 379,087 374,197 753,284
GGD 76-80 1941-1945 6 March 2021 575,824 567,673 1,143,497
GGD 71-75 1946-1950 6 April 2021 863,521 843,863 1,707,384
GGD 66-70 1951-1955 19 April 2021 805,253 779,937 1,585,190
GGD 61-65 1956-1960   149,467 163,021 312,488
GGD 56-60 1961-1965 27 April 2021 1,035,679 974,504 2,010,183
GGD 51-55 1966-1970 20 May 2021 1,048,904 774,521 1,823,425
GGD 46-50 1971-1975 26 May 2021 902,497 823,643 1,726,140
GGD 41-45 1976-1980 29 May 2021 794,583 670,226 1,464,809
GGD 36-40 1981-1985 1 June 2021 772,239 685,301 1,457,540
GGD 31-35 1986-1990 7 June 2021 784,972 682,401 1,467,373
GGD 26-30 1991-1995 11 June 2021 770,857 640,400 1,411,257
GGD 18-25 1996-2003 15 June 2021 1,248,026 926,802 2,174,828
GGD 12-17 2004-2009 22 June 2021 798,542 707,959 1,506,501
GGD Unknown Unknown   5,038 3,954 8,992
GPs (estimated)3,4,5     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,4,6     6 January 2021 940,525 482,801 1,423,326
Total6       13,360,350 11,444,690 24,805,040
  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  5. 222,356 estimated vaccinations administered by other vaccinators, and 645,636 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 3, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.6% 84.7%
18 years and older 2003 and before 89.2% 86.2%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

18 January 2022 | 16:00

Vaccination figures: 10 to 16 January 2022 

By Sunday 16 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  

Vaccination coverage for the basic series

It is estimated that 89.2% of all people over 18 have received at least one vaccination in the basic series, and 86.2% have completed the basic series. According to estimates, 87.5% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.6% have completed the basic series.

Major increase in number of booster vaccinations

By Sunday 16 January 2022, more than 7.7 million booster vaccinations and third vaccinations had been administered by the Municipal Public Health Services (GGDs) and other vaccinators. The GGD gave more than 6.7 million people their booster vaccination and more than 132,000 people with severely impaired immunity their third vaccination. It is estimated that other vaccinators, such as hospitals, GPs or care institutions that have their own medical service, administered a booster vaccination to another 827,000 people.

Vaccination coverage for the booster vaccination

It is estimated that 53.3% of all people over 18 have now received a booster vaccination.  We expect to include booster vaccination coverage by age group in this update within the near future.
 

Vaccination figures: 6 January 2021 – 16 January 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 2 (2022), by type of vaccinator.

 

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,735 67,148 135,883
GGD 86-90 1931-1935 29 January 2021 190,343 187,364 377,707
GGD 81-85 1936-1940 5 February 2021 379,062 374,135 753,197
GGD 76-80 1941-1945 6 March 2021 575,79 567,605 1,143,395
GGD 71-75 1946-1950 6 April 2021 863,456 843,733 1,707,189
GGD 66-70 1951-1955 19 April 2021 805,18 779,792 1,584,972
GGD 61-65 1956-1960   149,38 162,797 312,177
GGD 56-60 1961-1965 27 April 2021 1,035,519 974,032 2,009,551
GGD 51-55 1966-1970 20 May 2021 1,048,672 773,899 1,822,571
GGD 46-50 1971-1975 26 May 2021 902,218 822,824 1,725,042
GGD 41-45 1976-1980 29 May 2021 794,222 669,258 1,463,480
GGD 36-40 1981-1985 1 June 2021 771,69 684 1,455,690
GGD 31-35 1986-1990 7 June 2021 784,039 680,684 1,464,723
GGD 26-30 1991-1995 11 June 2021 769,731 638,508 1,408,239
GGD 18-25 1996-2003 15 June 2021 1,246,213 923,365 2,169,578
GGD 12-17 2004-2009 22 June 2021 796,622 704,667 1,501,289
GGD Unknown Unknown   6,022 3,81 9,832
GPs (estimated)3,4,5     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,4,6     6 January 2021 940,525 482,801 1,423,326
Total6       13,353,648 11,429,339 24,782,987

 

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  5. 222,356 estimated vaccinations administered by other vaccinators, and 645,502 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 2, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.5% 84.6%
18 years and older 2003 and before 89.2% 86.2%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

11 January 2022 | 16:00

Vaccination figures: 3 to 9 January 2022 

By Sunday 9 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  

Vaccination coverage for the basic series

It is estimated that 89.1% of all people over 18 have received at least one vaccination in the basic series, and 86.1% have completed the basic series. According to estimates, 87.4% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.5% have completed the basic series.

Major increase in number of booster vaccinations

By 9 January, 6.6 million booster vaccinations and third vaccinations had been administered. More than 5.6 million people have received their booster vaccination from the Municipal Public Health Services (GGDs). In addition, by 9 January, an estimated 801,000 people had received a booster vaccination from other vaccinators, such as hospitals, GPs or care institutions that have their own medical service. Since 6 October 2021, about 132,000 people with severely impaired immunity received their third vaccination from the GGD.

Vaccination coverage for the booster vaccination

It is estimated that 45.2% of all people over 18 have now received a booster vaccination. Starting next week, we expect to include booster vaccination coverage by age group in this update. 

Vaccination figures: 6 January 2021 – 9 January 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 (2021) to week 1 (2022), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,724 67,126 135,85
GGD 86-90 1931-1935 29 January 2021 190,315 187,301 377,616
GGD 81-85 1936-1940 5 February 2021 379,008 374,053 753,061
GGD 76-80 1941-1945 6 March 2021 575,733 567,473 1,143,206
GGD 71-75 1946-1950 6 April 2021 863,379 843,525 1,706,904
GGD 66-70 1951-1955 19 April 2021 805,069 779,5 1,584,569
GGD 61-65 1956-1960   149,266 162,419 311,685
GGD 56-60 1961-1965 27 April 2021 1,035,294 973,169 2,008,463
GGD 51-55 1966-1970 20 May 2021 1,048,358 772,787 1,821,145
GGD 46-50 1971-1975 26 May 2021 901,872 821,516 1,723,388
GGD 41-45 1976-1980 29 May 2021 793,767 668,06 1,461,827
GGD 36-40 1981-1985 1 June 2021 771,001 682,544 1,453,545
GGD 31-35 1986-1990 7 June 2021 782,922 678,75 1,461,672
GGD 26-30 1991-1995 11 June 2021 768,261 636,139 1,404,400
GGD 18-25 1996-2003 15 June 2021 1,243,845 919,002 2,162,847
GGD 12-17 2004-2009 22 June 2021 793,809 700,604 1,494,413
GGD Unknown Unknown   5,488 3,855 9,343
GPs (estimated)3,4,5     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,4,6     6 January 2021 940,525 482,801 1,423,326
Total6       13,342,865 11,409,541 24,752,406

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week1, 2022, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  5. 222,356 estimated vaccinations administered by other vaccinators, and 645,258 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 1, 20221-5

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.4% 84.5%
18 years and older 2003 and before 89.1% 86.1%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 1, 20221-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.

4 January 2022| 4:00 PM

Vaccination figures: 27 December 2021 - 2 January 2022

By Sunday 2 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and nearly 11.4 million were second vaccinations.  

Vaccination coverage for the basic series

It is estimated that 89.1% of all people over 18 have received at least one vaccination in the basic series, and 86.0% have completed the basic series. According to estimates, 87.4% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.4% have completed the basic series. 

Major increase in number of booster vaccinations

By Sunday 2 January 2022, more than 4.7 million booster vaccinations and third vaccinations had been administered. More than 3.8 million people have received their booster vaccination from the Municipal Public Health Services (GGDs). In addition, by 2 January, an estimated 731,000 people had received a booster vaccination from another vaccinator, such as hospitals, GPs or care institutions that have their own medical service. Since 6 October 2021, more than 131,000 people with severely impaired immunity have received their third vaccination from the GGD.

Vaccination coverage for the booster vaccination

It is estimated that 32.0% of all people over 18 have now received a booster vaccination. 

Vaccination figures: 6 January 2021 – 2 January 2022

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 52 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,715 67,101 135,816
GGD 86-90 1931-1935 29 January 2021 190,290 187,223 377,513
GGD 81-85 1936-1940 5 February 2021 378,946 373,910 752,856
GGD 76-80 1941-1945 6 March 2021 575,658 567,259 1,142,917
GGD 71-75 1946-1950 6 April 2021 863,275 843,173 1,706,448
GGD 66-70 1951-1955 19 April 2021 805,011 779,054 1,584,065
GGD 61-65 1956-1960   149,136 161,863 310,999
GGD 56-60 1961-1965 27 April 2021 1,035,079 972,050 2,007,129
GGD 51-55 1966-1970 20 May 2021 1,048,028 771,641 1,819,669
GGD 46-50 1971-1975 26 May 2021 901,464 820,111 1,721,575
GGD 41-45 1976-1980 29 May 2021 793,236 666,527 1,459,763
GGD 36-40 1981-1985 1 June 2021 770,361 680,809 1,451,170
GGD 31-35 1986-1990 7 June 2021 781,700 676,354 1,458,054
GGD 26-30 1991-1995 11 June 2021 766,678 633,286 1,399,964
GGD 18-25 1996-2003 15 June 2021 1,241,314 913,841 2,155,155
GGD 12-17 2004-2009 22 June 2021 788,700 694,740 1,483,440
GGD Unknown Unknown   4,918 3,739 8,657
GPs (estimated)3,4,5     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,4,6     6 January 2021 940,525 482,801 1,423,326
Total6       13,329,263 11,384,399 24,713,662

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 52, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
    Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
    It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
    The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign.
  5. 222,356 estimated vaccinations administered by other vaccinators, and 645,065 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  6. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 87.4% 84.4%
18 years and older 2003 and before 89.1% 86.0%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 52, 20211-5

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.